Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2303935
Max Phase: Preclinical
Molecular Formula: C21H24O8
Molecular Weight: 404.42
Molecule Type: Small molecule
Associated Items:
ID: ALA2303935
Max Phase: Preclinical
Molecular Formula: C21H24O8
Molecular Weight: 404.42
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C(=O)O)c1cccc(-c2ccccc2O[C@H]2O[C@H](CO)[C@@H](O)[C@@H](O)[C@@H]2O)c1
Standard InChI: InChI=1S/C21H24O8/c1-11(20(26)27)12-5-4-6-13(9-12)14-7-2-3-8-15(14)28-21-19(25)18(24)17(23)16(10-22)29-21/h2-9,11,16-19,21-25H,10H2,1H3,(H,26,27)/t11?,16-,17-,18-,19+,21+/m1/s1
Standard InChI Key: XUAXMFACEQLBHB-ZJVRTILUSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 404.42 | Molecular Weight (Monoisotopic): 404.1471 | AlogP: 0.72 | #Rotatable Bonds: 6 |
Polar Surface Area: 136.68 | Molecular Species: ACID | HBA: 7 | HBD: 5 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 4.19 | CX Basic pKa: | CX LogP: 1.23 | CX LogD: -1.81 |
Aromatic Rings: 2 | Heavy Atoms: 29 | QED Weighted: 0.48 | Np Likeness Score: 1.18 |
1. Kogan TP, Dupré B, Keller KM, Scott IL, Bui H, Market RV, Beck PJ, Voytus JA, Revelle BM, Scott D.. (1995) Rational design and synthesis of small molecule, non-oligosaccharide selectin inhibitors: (alpha-D-mannopyranosyloxy)biphenyl-substituted carboxylic acids., 38 (26): [PMID:8544173] [10.1021/jm00026a004] |
2. Kogan TP, Dupré B, Keller KM, Scott IL, Bui H, Market RV, Beck PJ, Voytus JA, Revelle BM, Scott D.. (1995) Rational design and synthesis of small molecule, non-oligosaccharide selectin inhibitors: (alpha-D-mannopyranosyloxy)biphenyl-substituted carboxylic acids., 38 (26): [PMID:8544173] [10.1021/jm00026a004] |
Source(1):